Radical retropubic prostatectomy: a review of outcomes and side-effects
- PMID: 21604947
- DOI: 10.3109/0284186X.2010.535848
Radical retropubic prostatectomy: a review of outcomes and side-effects
Abstract
Background: Radical prostatectomy (RP) is worldwide probably the most common procedure to treat localized prostate cancer (PC). Due to a more widespread use of Prostate-Specific Antigen (PSA) testing, patients operated today are often younger and have organ confined disease justifying a more preservative surgery. At the same time, surgical technique has improved resulting in lower risk of permanent side-effects. This paper aims to give an overview of results from modern surgery regarding cancer control and side-effects. A brief overview of the history is given.
Material and methods: A literature research identified recently published papers focusing on outcome and side-effects after RP.
Results: One large randomized study (SPCG-4) compared RP and watchful waiting (WW). The study showed that RP was superior to WW in preventing local progression (RR = 0.36), distant metastasis (RR = 0.65) and death from PC (RR = 0.65). Observational studies also show a better outcome for men treated with RP compared to WW. Peri-operative mortality after RP is low in most material around 0.1%. The risk of stricture of the vesico-urethral anastomosis has decreased with improved technique from historically 10-20% to a low incidence of around 2-9% today. Also the risk of incontinence has declined with improved technique. However, while the rates of severe incontinence is usually very low, as many as 30% still report light incontinence after long-term follow-up. Erectile dysfunction (ED) is still a frequent side-effect after RP. This risk is dependent on age, pre-operative sexual function, surgical technique and other risk factors for ED such as smoking, diabetes, etc. In selected subgroups the risk of ED is low. Inguinal hernia is a more recently described complication after open retropubic RP with a postoperative incidence of 15-20% within three years of surgery.
Conclusion: RP is an effective method to achieve cancer control in selected patients. With modern technique it is a safe procedure with a low risk of permanent side-effects except for ED.
Similar articles
-
Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.J Urol. 2000 Jun;163(6):1802-7. J Urol. 2000. PMID: 10799186
-
Surgical treatment of localized prostate cancer.Acta Oncol. 2005;44(6):599-604. doi: 10.1080/02841860510029734. Acta Oncol. 2005. PMID: 16165919 Review.
-
Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.Urology. 2004 Feb;63(2):337-41. doi: 10.1016/j.urology.2003.09.032. Urology. 2004. PMID: 14972485
-
Is radical prostatectomy the "gold standard" for localized prostate cancer?Am J Clin Oncol. 2010 Oct;33(5):511-5. doi: 10.1097/COC.0b013e3181b4af05. Am J Clin Oncol. 2010. PMID: 20010078 Review.
-
Robotic-assisted radical prostatectomy: a review of current outcomes.BJU Int. 2009 Nov;104(10):1428-35. doi: 10.1111/j.1464-410X.2009.08895.x. Epub 2009 Oct 5. BJU Int. 2009. PMID: 19804427 Review.
Cited by
-
TGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapy.J Cell Mol Med. 2014 Apr;18(4):555-67. doi: 10.1111/jcmm.12266. Epub 2014 Mar 15. J Cell Mol Med. 2014. PMID: 24629090 Free PMC article. Review.
-
Local Administration of Tranexamic Acid During Prostatectomy Surgery: Effects on Reducing the Amount of Bleeding.Nephrourol Mon. 2016 Aug 23;8(6):e40409. doi: 10.5812/numonthly.40409. eCollection 2016 Nov. Nephrourol Mon. 2016. PMID: 27896241 Free PMC article.
-
Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial).J Cancer Res Clin Oncol. 2021 Jan;147(1):235-242. doi: 10.1007/s00432-020-03327-2. Epub 2020 Sep 4. J Cancer Res Clin Oncol. 2021. PMID: 32886212 Free PMC article. Clinical Trial.
-
Prostate-specific antigen screening for prostate cancer: benefits for patients with highly aggressive prostate cancer.Asian J Androl. 2013 Mar;15(2):218-20. doi: 10.1038/aja.2012.130. Epub 2013 Jan 21. Asian J Androl. 2013. PMID: 23334201 Free PMC article.
-
Characterization of prostate microstructure using water diffusion and NMR relaxation.Front Phys. 2018 Sep;6:91. doi: 10.3389/fphy.2018.00091. Epub 2018 Sep 25. Front Phys. 2018. PMID: 30568939 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous